All stock lists
Unlock the score
Butterfly Network, Inc. (New York Stock Exchange:BFLY)
US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
7.28+0.61 (+9.23%)
Market cap
$1.94B
Insider Score
Health Score
Analyst consensus
Listed since
Jul 13, 2020
Website
Insider Score
/ 100
BFLY Insider Score
Butterfly Network, Inc. has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
Financial Health Score
Fair
From BFLY’s reported statements · Q2 2026 (trailing 12 months)
Profitability0 / 20
Loses money on what it sells.
- Revenue
- $112.1M
- Net income
- -$74.8M
- Net margin
- -66.7%
Leverage19 / 20
Little or no net debt.
- Total debt
- $19.1M
- Cash
- $124.7M
- Debt / equity
- 0.10
Liquidity20 / 20
Comfortably covers what is due within a year.
- Current assets
- $237.9M
- Current liabilities
- $58.6M
- Current ratio
- 4.06
Cash generation0 / 20
Consumes cash and must keep raising it.
- Operating cash flow
- -$24.0M
- Free cash flow
- -$28.0M
- FCF margin
- -25.0%
Dilution & runway13 / 20
Some dilution over the past year.
- Shares outstanding
- 262.1M
- Share growth (1y)
- 8.4%
- Cash runway
- 62 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
BFLY Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 32.61 M | 26.53 M | 31.51 M | 21.49 M | 23.38 M | 21.23 M |
| Revenue Growth (YoY) | 39.47 % | 24.99 % | 41.00 % | 4.51 % | 8.82 % | 20.21 % |
| Cost of Revenue | 9.32 M | 8.24 M | 10.29 M | 25.25 M | 8.49 M | 7.84 M |
| Gross Profit | 23.29 M | 18.29 M | 21.22 M | -3.76 M | 14.89 M | 13.38 M |
| SG&A Expense | 26.41 M | 22.62 M | 23.29 M | 19.91 M | 22.68 M | 21.92 M |
| R&D Expense | 10.54 M | 9.54 M | 9.32 M | 8.70 M | 8.31 M | 9.92 M |
| Operating Expenses | 36.95 M | 32.16 M | 40.69 M | 28.62 M | 30.99 M | 31.85 M |
| Operating Income | -13.66 M | -13.87 M | -19.47 M | -32.38 M | -16.10 M | -18.47 M |
| Pretax Income | -12.91 M | -12.68 M | -15.23 M | -33.95 M | -13.81 M | -13.96 M |
| Tax Provision | 0.00 | 0.00 | 66.00 K | 16.00 K | 20.00 K | 7.00 K |
| Net Income | -12.91 M | -12.68 M | -15.29 M | -33.97 M | -13.83 M | -13.97 M |
| EPS (Basic) | -0.05 | -0.05 | -0.06 | -0.13 | -0.06 | -0.06 |
| EPS (Diluted) | -0.05 | -0.05 | -0.06 | -0.13 | -0.06 | -0.06 |
| Shares Outstanding | 262.10 M | 256.52 M | 252.84 M | 252.09 M | 241.70 M | 234.92 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.